← Back to Search

Community Support for Primary Care for Urinary Incontinence (WI-INTUIT Trial)

N/A

Waitlist Available

Led By Heidi W Brown, MD, MAS

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients must be 18 years or older and be assigned female at birth

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months, 9 months, and 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial investigates if extra support for primary care practices leads to better implementation of healthcare tools.

Who is the study for?

This trial is for primary care practices ready to adopt UI-Assist for managing bedwetting and urinary incontinence. They must be willing to work with a facilitator, have patients over 18 assigned female at birth, and provide data from electronic health records. Some will also engage in partnership activities.

What is being tested?

The study is testing if primary care practices that build partnerships implement the UI-Assist program better than those with just basic practice facilitation. It's about improving continence promotion within community healthcare settings.

What are the potential side effects?

Since this trial focuses on implementation strategies rather than medical treatments, it does not directly involve medication side effects. However, changes in practice management could affect patient experience.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 or older and was assigned female at birth.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months, 9 months, and 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months, 9 months, and 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months, 9 months, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Differences in Screening Rates for Urinary Incontinence

Secondary study objectives

Change in response to Urinary Incontinence Assist Project Practice Survey

Change in response to a single-item burnout measure

Clinical Staff Questionnaire in the National Demonstration Project - Community knowledge

+15 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Streamlined Practice Facilitation (SPF) + Partnership Building (PB) implementation of UI-AssistExperimental Treatment2 Interventions

In addition to streamlined practice facilitation, those practices allocated to Streamlined Practice Facilitation plus Partnership Building (SPF+PB) will have facilitation and configurable solutions that engage community resources and enable coalition building. In addition to a MetaStar practice facilitator, a partnership facilitator from the Wisconsin Institute for Healthy Aging (WIHA) will identify existing local community resources with which the practice may choose to partner.

Group II: Streamlined Practice Facilitation (SPF) implementation of UI-AssistActive Control1 Intervention

Streamlined practice facilitation encompasses multiple well-established strategies from the Expert Recommendations for Implementing Change (ERIC) as field-tested in and updated after EvidenceNOW. To ensure the interventions and tools offered are consistent across practices, practice facilitators will receive training and support on UI-Assist, milestones, tracking tools for documenting changes made by sites, etc. according to a Practice Facilitation Training Manual and toolkit that will be built based on ones used for prior EvidenceNOW initiatives.

0 / 1Eligibility criteria met